← Back to Search

ChatBot Support for Cancer

N/A

Recruiting

Led By Arun Goel, MD

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults (age >18 years) with a diagnosis of a head and neck, lung, or gastrointestinal cancer, receiving concurrent chemotherapy and radiation treatment

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 13 weeks

Awards & highlights

Study Summary

This trial aims to use tech & monitoring to help cancer patients manage symptoms & decrease hospital visits.

Who is the study for?

Adults over 18 with head and neck, lung, or gastrointestinal cancer undergoing chemo and radiation can join. They must own a mobile device for texts and FitBit data, read/respond in English, and consent to the study. Bed-bound patients or those needing wheelchairs for walking cannot participate.Check my eligibility

What is being tested?

The trial is testing if using a chatbot along with activity monitoring via FitBit can help manage symptoms early on during cancer treatment. It aims to see if this reduces unnecessary clinic visits, emergency room trips, hospital stays, and treatment interruptions.See study design

What are the potential side effects?

There are no direct medical side effects from participating as the intervention involves using technology (chatbot) for communication and activity tracking rather than medication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult with cancer in my head, neck, lung, or gastrointestinal system and am receiving both chemotherapy and radiation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 13 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~13 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of triage visits

Secondary outcome measures

Count of emergency department visits

Count of treatment breaks

Count of unplanned inpatient hospitalization

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Activity Monitoring and ChatBotExperimental Treatment1 Intervention

Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring and utilize a ChatBot

Group II: Activity Monitoring without ChatBotActive Control1 Intervention

Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring alone

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

145,594 Total Patients Enrolled

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor

359 Previous Clinical Trials

104,994 Total Patients Enrolled

Arun Goel, MDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Activity Monitoring and ChatBot Clinical Trial Eligibility Overview. Trial Name: NCT05318027 — N/A

Lung Cancer Research Study Groups: Activity Monitoring without ChatBot, Activity Monitoring and ChatBot

Lung Cancer Clinical Trial 2023: Activity Monitoring and ChatBot Highlights & Side Effects. Trial Name: NCT05318027 — N/A

Activity Monitoring and ChatBot 2023 Treatment Timeline for Medical Study. Trial Name: NCT05318027 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this experiment accessible at the present time?

"According to official records, this research initiative is in need of enrollees. The trial was first published on the 22nd of May 2023 and has seen its most recent update occurring on July 19th 2023."

Answered by AI

What is the cap on enrollees for this experiment?

"Affirmative. Clinicaltrials.gov provides evidence that the trial, initially listed on May 22nd 2023, is actively looking for volunteers. 70 candidates are needed at a single research facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

2023. "ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05318027.